BioLegend

APC anti-mouse CD274 (B7-H1, PD-L1)

#124312 (also 124311) · flow cytometry

69
Citing papers
2.4k
Combined citations
Supplier page Find this product

Research areas

Immune cells in cancer12Cancer Immunotherapy and Biomarkers11Immunotherapy and Immune Responses6Immune Cell Function and Interaction5CAR-T cell therapy research5Cancer Research and Treatments4interferon and immune responses4Phagocytosis and Immune Regulation4

Papers citing this product

1
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Nature Communications·2017·346 cit.·DOI
2
A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma
Nature Communications·2023·179 cit.·DOI
3
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
Journal of Hematology & Oncology·2022·178 cit.·DOI
4
Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
Nature Communications·2020·122 cit.·DOI
5
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting
Nature Communications·2023·102 cit.·DOI
6
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy
Cell chemical biology·2023·86 cit.·DOI
7
BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
Nature Communications·2022·82 cit.·DOI
8
Lymphatic PD-L1 Expression Restricts Tumor-Specific CD8+ T-cell Responses
Cancer Research·2021·81 cit.·DOI
9
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
Journal for ImmunoTherapy of Cancer·2020·78 cit.·DOI
10
Development of Exhausted Memory Monocytes and Underlying Mechanisms
Frontiers in Immunology·2021·74 cit.·DOI

Also available from other vendors

This target has 140 citing papers across all vendors combined

VendorProductEvidencePricePapers
BioLegendBiotin anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendAPC anti-mouse CD274 (B7-H1, PD-L1)——1
BioLegendPE/Cyanine7 anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendPE/Cyanine7 anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendBrilliant Violet 421(TM) anti-mouse CD274 (B7-H1, PD-L1)——25
BioLegendPE anti-mouse CD274 (B7-H1, PD-L1)——49
BioLegendPE anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendBiotin anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendPurified anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendPurified anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendUltra-LEAF(TM) Purified anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendBrilliant Violet 711(TM) anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendBrilliant Violet 605(TM) anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendPE/Dazzle(TM) 594 anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendPE/Dazzle(TM) 594 anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendGoInVivo(TM) Purified anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendGoInVivo(TM) Purified anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendGoInVivo(TM) Purified anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendGoInVivo(TM) Purified anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendGoInVivo(TM) Purified anti-mouse CD274 (B7-H1, PD-L1)———
BioLegendGoInVivo(TM) Purified anti-mouse CD274 (B7-H1, PD-L1)———

Similar products

ProductVendorEvidencePricePapers
APC anti-mouse CD274 (B7-H1, PD-L1)RatBioLegend——1

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.